ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
0 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.0K
|
331K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
0 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.0K
|
331K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
2 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.0K
|
331K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
0 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
1.0K
|
331K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
CHF Accelerated Approval !
|
|
Spender
|
144 |
56K |
1 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
144
|
56K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Spender
|
905 |
290K |
1 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
905
|
290K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Lets survey. How many MSB stocks do you have?
|
|
Spender
|
24 |
9.1K |
6 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
24
|
9.1K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Half Year Report and Accounts
|
|
Spender
|
36 |
19K |
1 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
36
|
19K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: S&P DJI Announces March 2022 Quarterly Rebalance
|
|
Spender
|
96 |
31K |
1 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
96
|
31K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
2 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Spender
|
4.7K |
1.1M |
4 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
0 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
1 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
2 |
18/02/22 |
18/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Spender
|
1.0K |
331K |
2 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
Spender
|
451 |
115K |
3 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
451
|
115K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
Spender
|
451 |
115K |
3 |
05/02/22 |
05/02/22 |
ASX - By Stock
|
451
|
115K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer
|
|
Spender
|
147 |
42K |
0 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
147
|
42K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Who is ready for a 200%
|
|
Spender
|
4 |
1.3K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Spender
|
10K |
3.0M |
6 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Spender
|
850 |
253K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
253K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Spender
|
850 |
253K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
253K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Spender
|
850 |
253K |
0 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
253K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Spender
|
850 |
253K |
2 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
253K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Spender
|
850 |
253K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
850
|
253K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
Spender
|
953 |
291K |
0 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
953
|
291K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
15 Days until doubt is removed
|
|
Spender
|
953 |
291K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
953
|
291K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
2 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
1 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
0 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
1 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
0 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
0 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
1 |
03/12/21 |
03/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
2 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
2 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
2 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
2 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
4 |
01/12/21 |
01/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
1 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Spender
|
17K |
6.8M |
3 |
22/09/21 |
22/09/21 |
ASX - By Stock
|
17K
|
6.8M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
12 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
3 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
0 |
20/09/21 |
20/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Spender
|
10K |
3.0M |
1 |
17/07/21 |
17/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Spender
|
10K |
3.0M |
8 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
8
|
|
ASX - By Stock
|
BRN |
Re:
BRN Podcast
|
|
Spender
|
930 |
341K |
2 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
930
|
341K
|
2
|
|